I migliori medici di Enucleazione di tumore sul pancreas - TOP-48medici

Il Dr. Mustafa Solak è specializzato in tumori gastrointestinali, con formazione avanzata presso l'Istituto del Cancro dell'Università di Hacettepe e il MD Anderson Cancer Center.

• Ha completato una fellowship presso l'Università di Hacettepe – un leader nella ricerca oncologica
• Ha ricevuto formazione presso l'Ospedale di Formazione e Ricerca Sisli Etfal di Istanbul
• Ha un'esperienza vasta in casi complessi di cancro
• Lavora con un approccio multidisciplinare

Il Dr. Kemal Rasa è specializzato nell'enucleazione dei tumori pancreatici minimamente invasiva – con oltre 20 anni di esperienza chirurgica presso ospedali di eccellenza.

• Presidente della Surgical Infection Society - Europe
• Autore della Guida Nazionale per la Prevenzione delle Infezioni Chirurgiche
• Formatosi presso l'Università di Hacettepe – una delle principali scuole di medicina della Turchia
• Esegue interventi chirurgici complessi per il cancro pancreatico e tiroideo

Il Dott. Jaume Capdevila è specializzato nel trattamento del cancro al pancreas presso il Centro Médico Teknon, con vasta esperienza nei tumori digestivi.

• Ha completato una borsa di studio in Oncologia Endocrina presso l'Ospedale Universitario di Uppsala
• Membro della European Society of Medical Oncology (ESMO) e della American Society of Clinical Oncology (ASCO)
• Co-fondatore dello Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)

Il Prof. Dr. Samet Yardımcı è un chirurgo gastroenterologico di spicco con formazione specializzata presso l'MD Anderson Cancer Center di Houston.

• Laureato nel 2003 presso la Facoltà di Medicina dell'Università di Ankara
• Formazione in chirurgia avanzata del cancro e trapianti d'organo
• Primo in classifica in Turchia negli esami di specializzazione in chirurgia gastroenterologica
• Ha istituito unità di chirurgia per le malattie infiammatorie intestinali

Il Prof. Ofer Merimsky dirige l'Unità di Oncologia Ortopedica presso il Sourasky Medical Center con oltre 25 anni di esperienza specializzata nel trattamento complesso dei sarcomi.

• Professore associato specializzato in tumori dei tessuti molli e delle ossa
• Formazione presso l'Institut Gustave Roussy (Parigi) per una fellowship in sarcomi
• Membro della Facoltà ESMO per i sarcomi dei tessuti molli e delle ossa
• Ricerca pubblicata sull'immunologia dei tumori e oncogenetica

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. İlhami Soykan Barlas was born in the year 1977 in Istanbul Moda. He is graduated from Kadıköy Anadolu High School and Cerrahpaşa Faculty of Medicine. He was awarded the title of General Surgery Specialist after completing his general surgery specialization in Okmeydanı Training and Research Hospital in the year 2008. 

He went to Scotland 2 times in the years 2006-2007 and received advanced laparoscopic education. He awarded with ‘Certificate of Appreciation’ by the Ministry of Health of the Republic of Turkey in the year 2009 for his contributions to the establishment of Dr. Lütfi Kırdar Training and Research Hospital Burn Center and for his related works. 

After completing his compulsory service at Kastamonu İnebolu State Hospital between the years 2009-2011, resigned from his duty at the state owned institutions, returned to Istanbul and started to work in private sector. He has been working as kidney transplant and general surgery specialist in Florence Nightingale group of hospitals since the year 2013. Since the year 2017, he has been serving as academic Doctor Lecturer in Faculty of Medicine of Demiroğlu Science University. He has more than 20 articles published in national and international journals in general surgery and kidney transplant and more than 30 proceedings that are submitted in national and international congresses. 

He also has been the book editor and chapter author on kidney transplant and he also has been chapter author in various surgery books. Dr Soykan Barlas has been awarded the title ‘General Surgery Associate Professor’ in the year 2020. Currently, he has been working within the organization of Medical Park Group of Hospitals .

 EXPERIENCES 

 İstanbul Okmeydanı Training and Research Hospital 2003-2008 (Specialization Education ) 

 İstanbul Lütfi Kırdar Kartal Training and Research Hospital 2009 

 İnebolu State Hospital 2009-2011 (Compulsory Service Duty) 

 Private Hospitalium Şişli Hospital 2012-2013 

 Şişli Florence Nightingale Hospital Kidney and Pancreas Transplant Center 2013-2020 

 Demiroğlu Science University Faculty of Medicine Surgery Department Lecturer 2017- Present 

 İstanbul Florence Nightingale Hospital Kidney and Pancreas Transplant Center 2020- Present 

 Private Osmanoğlu Hospital Şişli 2020-2022 Medical Park Göztepe Hospital 2022- present.

SCIENTIFIC ARTICLES 

1.Soykan Barlas,ArzuAkan,YavuzEryavuz,GirayYavuz,SedatKamalı,Gülçin Kamalı: PrimaryHydatidosis of thegluteusmuscle:Report of a caseandreview of theliterature. Ind JSurg.2016; 78(2): 161–162. 

2.Metin Kement, Hakan Ahmet Acar, İlhami Soykan Barlas, Nihat Aksakal, Cem Gezen, Uygar Düzci, Mustafa Öncel: Clinical evaluation of a temporaryfecalcontainmentdevicefornonsurgicalfecaldiversion in perinealburns. Ulus Trauma Emergency Surgery Journal. 2011; 17(2): 123-127 

3.Bilgin Y, Hot S,BarlasIS,AkanA,Eryavuz Y:Short andlongtermresults of harmonicscalpelhemorrhoidectomyversusstaplerhemorrhoidopexy in treatment of hemorrhoidaldisease. Asian J Surg. 2015;38(4):214-9. 

4.Sinangil A, Celik V, Barlas S, Sakaci T, Koc Y, Basturk T, Akin EB, Ecder T. NewOnsetDiabetesAfterKidneyTransplantationandPretransplantHypoma gnesemia.ProgTransplant. 2016 Mar;26(1):55-61. doi: 10.1177/1526924816633949. 

5.Sinangil A, Celik V, Barlas S, Altunrende F, Akin EB, Ecder T. CalcifiedDouble J StentafterSequentialLiverandRenalTransplantationAssociatedtoprim aryOxalosis: Case Report. BANTAO journal, 2015;13(2), 97-99. 

6.Sinangil A, Celik V, Barlas S, KuskuCabuk F, Akin EB, Ecder T. A veryraretumor in a renaltransplantdonorcandidate: primarymesentericneuroendocrinetumor.InternationalJournal Of AdvancesIn Case Reports, 2015;2(4):244-249 

7.Sinangil A, Celik V, Barlas S, Akin EB, Ecder T. Shouldtransplantureter be stentedroutinelyor not?EurRevMedPharmacolSci. 2014;18(23):3551-6. 

8.Sinangil A, Celik V, Barlas S, Koc Y, Basturk T, Sakaci T, Akin EB, Ecder T. Theincidence of newonsetdiabetesaftertransplantationandrelatedfactors: Singlecenterexperience. Nefrologia, 2017;37(2):181-188. 

9.Akin EB, Aydogdu I, Barlas IS. Introducing RobotAssistedLaparoscopicDonorNephrectomyAfterExperienceInHandAssistedRetroperitoneoscopicApproach. TransplantProceedings 2019;51, 2221-222. 

10. Barlas IS, Aydogdu I, Sinangil A, Atan Ucar Z, Koc Y, Sardogan C, Akin EB. IncisionalComplicationsandCosmetic Evaluation AfterHand-AssistedRetroperitoneoscopicDonorNephrectomy. TransplantProceedings 2019; 51, 2215-2220. 

11. Barlas IS, Aydogdu I, Sinangil A, Atan Ucar Z, Koc Y, Ecder T, Akin EB. HandAssistedNephretomyPredisposesIncisionalHerniationInObeseL ivingDonors. TransplantProceedings 2019; 51, 2210-2214. 

12.Sinangil A, Atan Ucar Z, KocY, Barlas IS, Abouzahir S,Ecder ST, Akin EB. TheOutcome of DesensitizationTherapy in Immunologically High-risk KidneyTransplantation: Single-Center Experience. TransplantProceedings 2019; 51, 2268-2273 

13.GodeOguten E, Barlas IS, Akin EB. MentalDistressSymptomsand Life SatisfactionamongLivingKidneyDonors: FrequencyandAssociationwithSubjectiveEvaluations. TransplantProceedings 2019; 51, 2232-2236 

14. Atan Ucar Z,Sinangil A, Koc Y, Barlas IS, AbouzahirS, Ecder T, Akin EB. TheClinicalPrognosis Of TheRenalRetransplantPatients: A Single Center Experience. TransplantProceedings 2019;51, 2274- 2278. 

15. Barlas IS, Demir M, Akın EB. A single-center nineyearexperience in pediatrickidneytransplantation. Cumhuriyet MedicalJournal 2020; 42 (1), 126-135

Education and Expertise

Istanbul University, Istanbul Faculty of Medicine

Istanbul University, Cerrahpaşa Faculty of Medicine

Northwestern University, Transplantation Center

Dr. Lütfi Kırdar Kartal Training and Research Hospital

Bezmialem Faculty of Medicine, Department of General Surgery

Experience

1992 to 1997 – Research Assistant at Istanbul University, Cerrahpaşa Faculty of Medicine, Department of General Surgery

1998 to 2002 – Fellow at Northwestern University, Transplantation Unit

2003 to 2008 – Chief Assistant at Kartal Training and Research Hospital

2008 to 2011 – Associate Professor at Kartal Training and Research Hospital

2011 to 2013 – Associate Professor at Bezmialem University Faculty of Medicine, Department of General Surgery

2013 to 2018 – Associate Professor at Kartal Training and Research Hospital


Professional Memberships

-Deutsche Gesellschaft Für Chirurgie

-American Society for Transplantation

-Breast Surgery Association

-Trauma Association

-Hepatobiliary Surgery Association

-Colorectal Surgery Association

Il Dr. Hanifi Onalan è specializzato in interventi chirurgici addominali complessi, tra cui l'enucleazione di tumori del pancreas presso l'Ospedale Universitario Atlas.

• Oltre 20 anni di esperienza in chirurgia generale
• Esperto in chirurgie erniarie sia aperte che laparoscopiche
• Formazione in procedure endoscopiche avanzate come l'ERCP
• Membro del team chirurgico presso il Taksim Education and Research Hospital

Il medico è un chirurgo generale esperto con una vasta esperienza in varie istituzioni prestigiose. Il medico è stato affiliato alla Clinica di Chirurgia Generale dell'Università Medipol di Istanbul e ha contribuito alla Società Turca di Chirurgia del Colon e del Retto e alla Società Turca di Chirurgia dell'Ostomia. Il medico ha anche un background nella Società di Chirurgia Gastrointestinale di Malatya.<\/p>

L'istruzione include una laurea in medicina presso l'Università Tecnica di Karadeniz, Facoltà di Medicina, e una formazione in chirurgia generale presso l'Ospedale di Formazione e Ricerca Dr. Lütfi Kirdar di Istanbul Kartal.<\/p>

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Javier Centeno obtained his Doctorate in Medicine and Surgery from the University of Barcelona in 1988 and completed his specialization in General and Gastrointestinal Surgery at the Hospital de Mutua de Terrassa between 1989 and 1993.

Afterwards, Dr. Centeno completed additional training in the colorectal surgery department at the Mayo Clinic de Rochester, Minnesota (USA). Since 1993, Dr. Centeno has been a leading specialist in the surgery department at the Teknon Medical Center.

Clinical and scientific work:

Co-organizer of the Seminar on Endorectal Ultrasound Diagnostics. Advances in Colon, Rectum and Anus Surgery. Barcelona. March 1995.

"Visiting Surgeon" in the Department of Colorectal Surgery, Cleveland Clinic Florida, Fort Lauderdale, Florida, USA, February 1996.

Advanced Course in Laparoscopic Colorectal Surgery. ICARD. EITS, Strasbourg. November 2002.

Postgraduate student, associate professor of the Department of Urogynecoproctological Physiotherapy.

School of Nursing and Physiotherapy, University of Blanquerna. Ramon Llull University. Barcelona. 2003 2015

Accreditation by ERAS-Society (Sweden) in 2016.

Member of scientific communities:

Asociación Española de Cirujanos

· Societat Catalana de Cirurgia

· American Society of Colon and Rectal Surgeons y de la University of Minnesota Alumni Association.

La Dottoressa Viola Fox dirige la Clinica di Ematologia, Oncologia e Cure Palliative presso il BKZ Solingen – un centro oncologico interdisciplinare certificato.

• Specializzata in chemioterapia, immunoterapia e terapie mirate
• Specialista qualificata in genetica dal 2016
• Attiva nella ricerca di biologia molecolare per le malattie emato-oncologiche
• Membro di società oncologiche tedesche e americane

Membership in societies:

Expert of scientific journals 

Close co-operation with leading surgeons

Membership of the German Medical Association 

Specialities:

Introduction of new and modern techniques in the field of oncological surgery
General and visceral surgery

Minimally invasive surgery

Gastrointestinal oncology surgery

Oncological surgery

Haemorrhoids treatment

Additional clinical specialisation in minimally invasive and hernia surgery

Surgery and transplantation of the pancreas

Work Experience:

2005: Specialist in the field of surgery

2008: Appointed Senior Consultant specialising in pancreatic surgery and transplantation

2010: Coordinator of the Pancreatic Cancer Centre (Oncocert)

2013: Specialist in visceral surgery

2014: Managing Senior Physician, additional clinical specialisation in minimally invasive and hernia surgery

2019: Chief Surgeon of the Colorectal Cancer Centre Bochum (the first certified colorectal cancer centre in Germany and one of the first certified leading colorectal centres in Europe)

2021: Chief Surgeon of the Department of Surgery at the Academic Hospital Solingen

Thanks to the professor and his team, the department has been modernised by introducing modern surgical methods of treatment and especially improved methods of post-operative recovery. The Department of Surgery at the Solingen Clinic is now further expanding its focus on minimally invasive surgery in the direction of robotics. The clinic has allocated a huge budget for the purchase of state-of-the-art equipment in order to offer patients a full range of surgical methods for the treatment of benign and malignant diseases of the oesophagus, lungs, stomach, liver, pancreas and intestines according to current guidelines and using the most modern technical equipment.

Professor Schenker is an active researcher and lecturer. He lectures at medical universities and organises seminars and workshops for colleagues. He cooperates closely with the Cancer Centre, the Pancreatic Cancer Treatment Centre, the Intestinal Cancer Treatment Centre and the Interregional Trauma Centre.

Il medico è un chirurgo addominale specializzato in procedure sia aperte che minimamente invasive, inclusa la chirurgia di Whipple. Con oltre 20 anni di esperienza, il medico guida il Dipartimento di Chirurgia Colorettale al Sourasky Medical Center, dimostrando competenza nelle tecniche chirurgiche avanzate e nella cura del paziente.<\/p>

Il dottore si è laureato all'Università di Grodno, Bielorussia, e ha ottenuto la licenza medica in Israele nel 2000. Specializzandosi in medicina interna e oncologia, il dottore ha completato tirocini nel 10° Dipartimento di Medicina Interna e Oncologia presso il Centro Medico di Tel Aviv, Ichilov. Dal 2015, il dottore è direttore del reparto di ospedalizzazione oncologica nello stesso centro.<\/p>

Con una vasta esperienza come ricercatore primario e secondario, il dottore ha partecipato a studi clinici di prima, seconda e terza fase in oncologia, contribuendo significativamente al campo.<\/p>

Il medico è specializzato in chirurgia colorettale, pancreatica e gastrointestinale, con una particolare esperienza nelle procedure di Whipple. Con oltre 45 anni di pratica, il medico è riconosciuto come uno dei principali chirurghi di Whipple in Israele.<\/p>